These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29876775)

  • 41. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers.
    Seeger H; Kaelin A; Ferraro PM; Weber D; Jaeger P; Ambuehl P; Robertson WG; Unwin R; Wagner CA; Mohebbi N
    BMC Nephrol; 2017 Dec; 18(1):349. PubMed ID: 29202723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relevance of Mediterranean diet and glucose metabolism for nephrolithiasis in obese subjects.
    Soldati L; Bertoli S; Terranegra A; Brasacchio C; Mingione A; Dogliotti E; Raspini B; Leone A; Frau F; Vignati L; Spadafranca A; Vezzoli G; Cusi D; Battezzati A
    J Transl Med; 2014 Feb; 12():34. PubMed ID: 24502605
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Essential arterial hypertension and stone disease.
    Borghi L; Meschi T; Guerra A; Briganti A; Schianchi T; Allegri F; Novarini A
    Kidney Int; 1999 Jun; 55(6):2397-406. PubMed ID: 10354288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence.
    Lee SC; Kim YJ; Kim TH; Yun SJ; Lee NK; Kim WJ
    J Urol; 2008 Feb; 179(2):570-4. PubMed ID: 18078957
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of nephrolithiasis on kidney function.
    Sigurjonsdottir VK; Runolfsdottir HL; Indridason OS; Palsson R; Edvardsson VO
    BMC Nephrol; 2015 Aug; 16():149. PubMed ID: 26316205
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Twenty-four-hour urine chemistries and the risk of kidney stones among women and men.
    Curhan GC; Willett WC; Speizer FE; Stampfer MJ
    Kidney Int; 2001 Jun; 59(6):2290-8. PubMed ID: 11380833
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dyslipidemia and kidney stone risk.
    Torricelli FC; De SK; Gebreselassie S; Li I; Sarkissian C; Monga M
    J Urol; 2014 Mar; 191(3):667-72. PubMed ID: 24055417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute acid load in recurrent oxalate stone formers.
    Knispel HH; Fitzner R; Kaiser M; Butz M
    Urol Int; 1988; 43(2):93-6. PubMed ID: 3388639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Do Overweight and Obese Pediatric Stone Formers Have Differences in Metabolic Abnormalities Compared With Normal-weight Stone Formers?
    Cambareri GM; Giel DW; Bayne AP; Corbett S; Schurtz E; Kovacevic L; Sukhu T; Yap M; Chiang G
    Urology; 2017 Mar; 101():26-30. PubMed ID: 27641936
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diabetic kidney stone formers excrete more oxalate and have lower urine pH than nondiabetic stone formers.
    Eisner BH; Porten SP; Bechis SK; Stoller ML
    J Urol; 2010 Jun; 183(6):2244-8. PubMed ID: 20400141
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of dietary counseling on urinary stone risk parameters in recurrent stone formers.
    Ortiz-Alvarado O; Miyaoka R; Kriedberg C; Moeding A; Stessman M; Anderson JK; Monga M
    J Endourol; 2011 Mar; 25(3):535-40. PubMed ID: 21361824
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of urine sodium on urine risk factors for calcium oxalate nephrolithiasis.
    Eisner BH; Eisenberg ML; Stoller ML
    J Urol; 2009 Nov; 182(5):2330-3. PubMed ID: 19758639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The characteristics of the stone and urine composition in Chinese stone formers: primary report of a single-center results.
    Wu W; Yang D; Tiselius HG; Ou L; Liang Y; Zhu H; Li S; Zeng G
    Urology; 2014 Apr; 83(4):732-7. PubMed ID: 24485999
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Renal ammonium excretion after an acute acid load: blunted response in uric acid stone formers but not in patients with type 2 diabetes.
    Bobulescu IA; Maalouf NM; Capolongo G; Adams-Huet B; Rosenthal TR; Moe OW; Sakhaee K
    Am J Physiol Renal Physiol; 2013 Nov; 305(10):F1498-503. PubMed ID: 24026180
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of Urinary Inhibitor or Promoter Activity in Uric Acid Nephrolithiasis.
    Doizi S; Rodgers K; Poindexter J; Sakhaee K; Maalouf NM
    J Urol; 2016 Jun; 195(6):1799-804. PubMed ID: 26723865
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fasting versus 24-h urine pH in the evaluation of nephrolithiasis.
    Capolongo G; Sakhaee K; Pak CY; Maalouf NM
    Urol Res; 2011 Oct; 39(5):367-72. PubMed ID: 21336574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Adequacy of a single 24-hour urine collection for metabolic evaluation of recurrent nephrolithiasis.
    Castle SM; Cooperberg MR; Sadetsky N; Eisner BH; Stoller ML
    J Urol; 2010 Aug; 184(2):579-83. PubMed ID: 20639021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low urine citrate excretion as main risk factor for recurrent calcium oxalate nephrolithiasis in males.
    Cupisti A; Morelli E; Lupetti S; Meola M; Barsotti G
    Nephron; 1992; 61(1):73-6. PubMed ID: 1528345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.